Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
PUT
Banco Bradesco
BBD
$38.3B
| $2.33M | ﹤0.01% |
380,597
+241,364
| +173% | +$1.6M |
|
2652
PUT
Omnicom Group
OMC
$21.5B
| $2.33M | ﹤0.01% |
29,700
-9,100
| -23% | -$723K |
|
2653
Charles River Laboratories
CRL
$11.2B
| $2.32M | ﹤0.01% |
17,545
-28,059
| -62% | -$3.76M |
|
2654
ProShares Short S&P500
SH
$908M
| $2.32M | ﹤0.01% |
22,230
+5,990
| +37% | +$633K |
|
|
MBT
2655
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $2.32M | ﹤0.01% |
286,658
-150,569
| -34% | -$1.24M |
|
|
ZAYO
2656
PUT
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.32M | ﹤0.01% |
68,500
-5,600
| -8% | -$189K |
|
2657
CALL
Caesars Entertainment
CZR
$6.06B
| $2.32M | ﹤0.01% |
58,200
+2,800
| +5% | +$119K |
|
2658
CALL
Fastenal
FAST
$54.3B
| $2.32M | ﹤0.01% |
142,000
-188,000
| -57% | -$2.92M |
|
2659
Ameris Bancorp
ABCB
$5.88B
| $2.32M | ﹤0.01% |
57,630
+9,730
| +20% | +$367K |
|
2660
PUT
Brighthouse Financial
BHF
$3.58B
| $2.32M | ﹤0.01% |
57,300
-9,300
| -14% | -$346K |
|
2661
Invesco S&P MidCap Low Volatility ETF
XMLV
$753M
| $2.32M | ﹤0.01% |
44,062
+17,407
| +65% | +$903K |
|
2662
Enanta Pharmaceuticals
ENTA
$369M
| $2.32M | ﹤0.01% |
38,565
+10,545
| +38% | +$783K |
|
2663
Fidelity International Multifactor ETF
FDEV
$287M
| $2.31M | ﹤0.01% |
90,000
| – | – |
|
2664
Amplify Alternative Harvest ETF
MJ
$102M
| $2.31M | ﹤0.01% |
9,281
+6,937
| +296% | +$2.24M |
|
2665
Sinclair Inc
SBGI
$986M
| $2.31M | ﹤0.01% |
53,990
+8,140
| +18% | +$394K |
|
|
JBTM
2666
JBT Marel
JBTM
$7.23B
| $2.31M | ﹤0.01% |
23,205
+2,790
| +14% | +$307K |
|
|
GRA
2667
DELISTED
W.R. Grace & Co.
GRA
| $2.31M | ﹤0.01% |
34,575
+10,375
| +43% | +$727K |
|
2668
Darling Ingredients
DAR
$9.67B
| $2.31M | ﹤0.01% |
120,582
+101,605
| +535% | +$1.99M |
|
2669
ICL Group
ICL
$6.57B
| $2.3M | ﹤0.01% |
463,844
+205,882
| +80% | +$1.03M |
|
2670
Protolabs
PRLB
$1.77B
| $2.3M | ﹤0.01% |
22,505
+11,938
| +113% | +$1.22M |
|
2671
iShares MSCI South Korea ETF
EWY
$22.2B
| $2.29M | ﹤0.01% |
40,705
+17,860
| +78% | +$988K |
|
|
ENBL
2672
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $2.29M | ﹤0.01% |
190,290
-37,629
| -17% | -$491K |
|
2673
Ironwood Pharmaceuticals
IRWD
$693M
| $2.29M | ﹤0.01% |
266,201
+228,615
| +608% | +$2.22M |
|
|
NOAH
2674
Noah Holdings
NOAH
$577M
| $2.28M | ﹤0.01% |
78,231
-5,652
| -7% | -$180K |
|
|
INST
2675
DELISTED
Instructure, Inc.
INST
| $2.28M | ﹤0.01% |
58,896
+24,044
| +69% | +$980K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.